Nephros (NEPH) Net Income towards Common Stockholders (2010 - 2026)
Nephros (NEPH) posted quarterly Net Income towards Common Stockholders of $29000.0 for Q1 2026, up 103.23% year-over-year from $14269.8 in Q1 2025, and down 53.23% quarter-over-quarter from $62000.0 in Q4 2025.
Nephros (NEPH) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
Nephros' Net Income towards Common Stockholders history runs 17 years deep, the most recent figure standing at $29000.0 for Q1 2026.
- In Q1 2026, Net Income towards Common Stockholders rose 103.23% year-over-year to $29000.0; the TTM figure through Mar 2026 stood at $665000.0 (up 203.74% YoY), while the FY2025 annual figure was $1.2 million, up 1513.51% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at $29000.0, down from $62000.0 in the prior quarter.
- The five-year high for Net Income towards Common Stockholders was $364000.0 in Q4 2024, with the low at -$3.2 million in Q3 2022.
- The 5-year median for Net Income towards Common Stockholders is -$289000.0 (2024), against an average of -$537705.9.
- The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders jumped 200.55% in 2024, then sank 332.21% in 2025.
- Nephros' Net Income towards Common Stockholders stood at -$918000.0 in 2022, then advanced by 28.76% to -$654000.0 in 2023, then soared by 155.66% to $364000.0 in 2024, then tumbled by 82.97% to $62000.0 in 2025, then sank by 53.23% to $29000.0 in 2026.
- Business Quant data shows NEPH's Net Income towards Common Stockholders at $29000.0 in Q1 2026, $62000.0 in Q4 2025, and $337000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 378.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 383.43 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 139.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 93.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 126.00 Mn |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn | 1.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.20 Mn |
| Mar 31, 2026 | 29,000.00 |
| Dec 31, 2025 | 62,000.00 |
| Sep 30, 2025 | 337,000.00 |
| Jun 30, 2025 | 237,000.00 |
| Mar 31, 2025 | -899,000.00 |
| Dec 31, 2024 | 364,000.00 |
| Sep 30, 2024 | 183,000.00 |
| Jun 30, 2024 | -289,000.00 |
| Mar 31, 2024 | -208,000.00 |
| Dec 31, 2023 | -654,000.00 |
| Sep 30, 2023 | -182,000.00 |
| Jun 30, 2023 | -433,000.00 |
| Mar 31, 2023 | -306,000.00 |
| Dec 31, 2022 | -918,000.00 |
| Sep 30, 2022 | -3.23 Mn |
| Jun 30, 2022 | -1.20 Mn |
| Mar 31, 2022 | -2.03 Mn |
| Dec 31, 2021 | -1.10 Mn |
| Sep 30, 2021 | -1.22 Mn |